Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
3.
An Med Interna ; 24(4): 177-8, 2007 Apr.
Article in Spanish | MEDLINE | ID: mdl-17867901

ABSTRACT

We present a case of systemic lupus erythematosus complicated by pancytopenia and visceral leishmaniasis in Spain. The literature on opportunistic infection in lupus erythematosus is reviewed.Leishmaniasis is a group of infections caused by the protozoa Leishmania, which is endemic in the Mediterranean basin. These opportunistic infections are an emerging entity in immunosuppressed patients. The use of immunosuppressive treatment in systemic lupus erythematosus modifies natural defense patterns and increases the risk of visceral leishmaniasis in endemic areas.


Subject(s)
Leishmaniasis, Visceral/etiology , Lupus Erythematosus, Systemic/complications , Adult , Amphotericin B/administration & dosage , Amphotericin B/therapeutic use , Antiprotozoal Agents/administration & dosage , Antiprotozoal Agents/therapeutic use , Female , Follow-Up Studies , Humans , Immunosuppression Therapy/adverse effects , Leishmaniasis, Visceral/diagnosis , Leishmaniasis, Visceral/drug therapy , Lupus Erythematosus, Systemic/drug therapy , Lupus Erythematosus, Systemic/immunology , Pancytopenia/etiology , Time Factors
4.
An. med. interna (Madr., 1983) ; 24(4): 177-178, abr. 2007.
Article in Es | IBECS | ID: ibc-055505

ABSTRACT

Presentamos un caso de lupus eritematoso sistémico complicado con pancitopenia y leishmaniasis visceral ocurrido en España. A propósito del mismo, realizamos una revisión bibliográfica sobre infecciones oportunistas en el lupus eritematoso sistémico. La leishmaniasis es un grupo de enfermedades causadas por el protozoo Leishmania, endémica en la cuenca mediterránea y de carácter oportunista y emergente en pacientes inmunodeprimidos. El uso de inmunosupresores en el tratamiento del lupus eritematoso sistémico induce modificaciones en la defensa natural, aumentando el riesgo de aparición de leishmaniasis visceral en zonas endémicas


We present a case of systemic lupus erythematosus complicated by pancytopenia and visceral leishmaniasis in Spain. The literature on opportunistic infection in lupus erythematosus is reviewed. Leishmaniasis is a group of infections caused by the protozoa Leishmania, which is endemic in the Mediterranean basin. These opportunistic infections are an emerging entity in immunosuppressed patients. The use of immunosuppressive treatment in systemic lupus erythematosus modifies natural defense patterns and increases the risk of visceral leishmaniasis in endemic areas


Subject(s)
Female , Adult , Humans , Opportunistic Infections/complications , Opportunistic Infections/diagnosis , Opportunistic Infections/therapy , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/diagnosis , Immunosuppressive Agents/therapeutic use , Interferons/therapeutic use , Amphotericin B/therapeutic use , Pancytopenia/complications , Leishmaniasis, Visceral/complications , Antiphospholipid Syndrome/complications , Antiphospholipid Syndrome/diagnosis , Prednisone/therapeutic use , Calcium/therapeutic use , Vitamin D/therapeutic use , Omeprazole/therapeutic use
7.
Rev. esp. enferm. metab. óseas (Ed. impr.) ; 11(4): 146-149, jul. 2002. ilus, tab
Article in Es | IBECS | ID: ibc-19184

ABSTRACT

La osteoporosis es una enfermedad con una alta prevalencia en nuestro medio y en nuestros hospitales. La mayoría de estos casos corresponde a casos de osteoporosis primaria. La enfermedad celíaca debe ser considerada en el diagnóstico diferencial de la osteoporosis, pues existe una alta prevalencia de osteoporosis en los enfermos de celiaquía. La osteoporosis además puede ser la única manifestación de enfermedad celíaca del adulto, debiendo considerarse como manifestación y consecuencia de la enfermead celíaca (AU)


Subject(s)
Adult , Female , Male , Humans , Osteoporosis/etiology , Celiac Disease/complications , Osteoporosis/drug therapy , Celiac Disease/diet therapy , Duodenum/pathology
9.
An Med Interna ; 11(2): 77-9, 1994 Feb.
Article in Spanish | MEDLINE | ID: mdl-8193238

ABSTRACT

We present the case of a patient under corticosteroid therapy (Deflazacort) developing a cutaneous Kaposi's Sarcoma. In a latter study performed due to the presence of digestive syndrome, a gastric Kaposi's sarcoma was detected. We review the cases published in the literature of patients with rheumatoid pathology under corticosteroid therapy.


Subject(s)
Arthritis, Rheumatoid/complications , Sarcoma, Kaposi/complications , Stomach Neoplasms/complications , Aged , Anti-Inflammatory Agents/therapeutic use , Arthritis, Rheumatoid/drug therapy , Humans , Male , Pregnenediones/therapeutic use
10.
An Med Interna ; 10(6): 290-2, 1993 Jun.
Article in Spanish | MEDLINE | ID: mdl-8392874

ABSTRACT

We present a case of nodose polyarteritis (NPA) in a 65-years-old man with clinical manifestations at the level of the peripherical nervous system (PNS) as a subacute sensorimotor polyneuropathy. We believe that this is an interesting case due to the outlined symptomatology and the first clinical signs, not as common as the multiple mononeuropathy. The diagnosis was established through biopsy of muscle-nerve, without observing aneurysms at the Divas and with negative results for the Hepatitis B markers. Response to corticoid and immunosuppressive therapy was positive.


Subject(s)
Arteritis/complications , Peripheral Nervous System Diseases/etiology , Aged , Humans , Male , Peripheral Nervous System Diseases/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...